Skip to content

Clinical application of artificial intelligence in predicting the occurrence of atrial high frequency events in patients after cardiovascular implantable electronic device surgery

Clinical application of artificial intelligence in predicting the occurrence of atrial high frequency events in patients after cardiovascular implantable electronic device surgery

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101956
Enrollment
Unknown
Registered
2025-05-06
Start date
2025-05-06
Completion date
Unknown
Last updated
2025-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sick sinus syndrome

Interventions

Gold Standard:1, Chinese Expert Consensus on the Evaluation and Management of Patients with Bradycardia and Conduction Abnormalities (2020)
2,An atrial high-frequency event was defined as an atrial frequency of >175 to 220 beats/minute with a duration
2. Chinese Expert Consensus on the Clinical Application of T
Index test:The data collected on patients with atrial high frequency events after cardiovascular implantable electronic devices include general information, epidemiological indicators
pre-implantation routine electrocardiogram and transthoracic echocardiography data
laboratory test indicators: biochemical

Sponsors

The First Hospital Of Jiaxing
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: A retrospective analysis was performed for patients with cardiac dual-chamber pacemakers, ICDs, and CRTs implanted in the First Hospital of Jiaxing City, the Affiliated Hospital of Jiaxing University from January 2019 to December 2025, with electrode leads implanted in the atria and ventricles, and good atrial sensing function. There were 1000 patients with AHRE events within 2 years of postoperative follow-up. The types of devices are ordinary dual-chamber pacemakers, and the brand of devices includes: Medtronic, Abbott, BIOTRONIK, Boston Scientific, and Creative Medical; Of these, 700 were used to build predictive models and 300 were used to validate predictive models.

Exclusion criteria

Exclusion criteria: Patients with severe hepatic insufficiency (aspartate aminotransferase/alanine aminotransferase levels >=3 times the upper limit of normal) or severe renal insufficiency (serum creatinine level >=3.5 mg/dL or creatinine clearance <=30 mL/min) were excluded, including those requiring dialysis; Pregnant or lactating patients; or those with malignancy, severe valvular heart disease, or a life expectancy of <=12 months since enrollment. Patients with high-frequency atrial events prior to device implantation, e.g., patients with brachy-slow syndrome.

Design outcomes

Primary

MeasureTime frame
Atrial high-rate episodes;

Countries

China

Contacts

Public ContactSun Xianchao

The Affiliated Hospital of Jiaxing University and the First Hospital of Jiaxing City

603495986@qq.com+86 573 82519652

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026